An announcement from Zymeworks (ZYME) is now available.
Zymeworks Inc. has appointed the seasoned executive Leone Patterson as their new Executive Vice President, Chief Business Officer, and Chief Financial Officer, effective September 1, 2024. Bringing a wealth of experience from her previous CFO and executive roles in various biotech firms, Patterson’s financial expertise and industry knowledge are expected to bolster Zymeworks’ leadership. Her compensation includes a base salary, potential bonuses, stock options, and benefits, with provisions for severance under certain conditions. This strategic hire follows the company’s expansion of its Inducement Stock Option and Equity Compensation Plan, aiming to drive future growth.
Find detailed analytics on ZYME stock on TipRanks’ Stock Analysis page.
